Sofia Castro Oliveira1,2,3, J S Neves4,5,6, P Souteiro4,5,6, J Pedro4,5,6, D Magalhães4,5,6, V Guerreiro4,5,6, R Bettencourt-Silva4,5,6, M M Costa4,5,6, A Varela4,5,7, I Barroso8,9, P Freitas4,5,6,7, D Carvalho4,5,6. 1. Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal. sofiacastro.oliveira@gmail.com. 2. Faculty of Medicine, University of Porto, Porto, Portugal. sofiacastro.oliveira@gmail.com. 3. Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal. sofiacastro.oliveira@gmail.com. 4. Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal. 5. Faculty of Medicine, University of Porto, Porto, Portugal. 6. Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal. 7. Multidisciplinary Group for Surgical Management of Obesity, Centro Hospitalar Universitário de São João, Porto, Portugal. 8. Department of Clinical Pathology, Centro Hospitalar Universitário de São João, Porto, Portugal. 9. EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
Abstract
INTRODUCTION: Several reports highlight bariatric surgery as an efficient and long-lasting strategy for weight loss. Herein, we aimed to evaluate the impact of bariatric surgery on 10-year cardiovascular disease (CVD) risk and to compare the effectiveness of different surgical procedures, employing the Framingham Risk Score (FRS). METHODS: Retrospective longitudinal observational study of patients undergoing bariatric surgery. Data was assessed preoperatively and during a 4-year follow-up period. RESULTS: We evaluated 1449 individuals, 85.2% female, age of 42.4 ± 10.6 years, and preoperative BMI of 44.3 ± 5.8 kg/m2; 58.0% underwent Roux-en-Y gastric bypass (RYGB), 23.4% sleeve gastrectomy (SG), and 18.6% adjustable gastric band (AGB). The 10-year CVD risk decreased 43.6% in the first postoperative year. The decrease in FRS was more pronounced in the RYGB group (50.5% in the first postoperative year) (p < 0.001). Although there was a subsequent slight increase in FRS during the follow-up period, the cardiovascular benefits were maintained when compared with baseline. For all surgical procedures, CVD risk showed a quadratic trend with a J-shaped curve. A negative interaction between the RYGB group CVD risk and time was observed (β = - 0.072 (95% CI, - 0.109; - 0.035)). In the RYGB group, FRS decreased more when compared with the SG and AGB groups and, from the second postoperative year onwards, increased more slowly, regardless of gender. The SG group showed similar trend as that of the AGB (β = - 0.002 (95% CI, - 0.049; 0.053)). CONCLUSION: Our study showed a significant reduction of 10-year CVD risk after bariatric surgery. This decrease was more pronounced in the first postoperative year, and RYGB was the procedure with the greatest decrease of the 10-year CVD risk.
INTRODUCTION: Several reports highlight bariatric surgery as an efficient and long-lasting strategy for weight loss. Herein, we aimed to evaluate the impact of bariatric surgery on 10-year cardiovascular disease (CVD) risk and to compare the effectiveness of different surgical procedures, employing the Framingham Risk Score (FRS). METHODS: Retrospective longitudinal observational study of patients undergoing bariatric surgery. Data was assessed preoperatively and during a 4-year follow-up period. RESULTS: We evaluated 1449 individuals, 85.2% female, age of 42.4 ± 10.6 years, and preoperative BMI of 44.3 ± 5.8 kg/m2; 58.0% underwent Roux-en-Y gastric bypass (RYGB), 23.4% sleeve gastrectomy (SG), and 18.6% adjustable gastric band (AGB). The 10-year CVD risk decreased 43.6% in the first postoperative year. The decrease in FRS was more pronounced in the RYGB group (50.5% in the first postoperative year) (p < 0.001). Although there was a subsequent slight increase in FRS during the follow-up period, the cardiovascular benefits were maintained when compared with baseline. For all surgical procedures, CVD risk showed a quadratic trend with a J-shaped curve. A negative interaction between the RYGB group CVD risk and time was observed (β = - 0.072 (95% CI, - 0.109; - 0.035)). In the RYGB group, FRS decreased more when compared with the SG and AGB groups and, from the second postoperative year onwards, increased more slowly, regardless of gender. The SG group showed similar trend as that of the AGB (β = - 0.002 (95% CI, - 0.049; 0.053)). CONCLUSION: Our study showed a significant reduction of 10-year CVD risk after bariatric surgery. This decrease was more pronounced in the first postoperative year, and RYGB was the procedure with the greatest decrease of the 10-year CVD risk.
Authors: R Nerla; P Tarzia; A Sestito; A Di Monaco; F Infusino; D Matera; F Greco; R M Tacchino; G A Lanza; F Crea Journal: Nutr Metab Cardiovasc Dis Date: 2010-12-24 Impact factor: 4.222
Authors: Lars Sjöström; Markku Peltonen; Peter Jacobson; C David Sjöström; Kristjan Karason; Hans Wedel; Sofie Ahlin; Åsa Anveden; Calle Bengtsson; Gerd Bergmark; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Kristina Narbro; Ingmar Näslund; Torsten Olbers; Per-Arne Svensson; Lena M S Carlsson Journal: JAMA Date: 2012-01-04 Impact factor: 56.272
Authors: Matthew L Maciejewski; David E Arterburn; Lynn Van Scoyoc; Valerie A Smith; William S Yancy; Hollis J Weidenbacher; Edward H Livingston; Maren K Olsen Journal: JAMA Surg Date: 2016-11-01 Impact factor: 14.766
Authors: Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Sayeed Ikramuddin; Judith Korner; Wei-Jei Lee; John E Connett; William B Inabnet; Charles J Billington; Avis J Thomas; Daniel B Leslie; Keong Chong; Robert W Jeffery; Leaque Ahmed; Adrian Vella; Lee-Ming Chuang; Marc Bessler; Michael G Sarr; James M Swain; Patricia Laqua; Michael D Jensen; John P Bantle Journal: JAMA Date: 2013-06-05 Impact factor: 56.272
Authors: Haris Riaz; Muhammad Shahzeb Khan; Tariq Jamal Siddiqi; Muhammad Shariq Usman; Nishant Shah; Amit Goyal; Sadiya S Khan; Farouk Mookadam; Richard A Krasuski; Haitham Ahmed Journal: JAMA Netw Open Date: 2018-11-02
Authors: Anirban Basu; Lee J Barton; Heidi Fischer; Kristi Reynolds; David E Arterburn; Douglas Barthold; Anita Courcoulas; Cecelia L Crawford; Peter N Fedorka; Benjamin B Kim; Edward C Mun; Sameer B Murali; Robert E Zane; Karen J Coleman Journal: Surg Obes Relat Dis Date: 2022-03-09 Impact factor: 3.709
Authors: Valerio Ceriani; Ferdinando Pinna; Antonio Galantino; Ahmed S Zakaria; Roberto Manfrini; Antonio E Pontiroli; Franco Folli Journal: Acta Diabetol Date: 2021-08-28 Impact factor: 4.280
Authors: Andressa Bressan Malafaia; Paulo Afonso Nunes Nassif; Ricardo Wallace das Chagas Lucas; Rodrigo Ferreira Garcia; José Guilherme Agner Ribeiro; Laura Brandão DE Proença; Maria Eduarda Mattos; Bruno Luiz Ariede Journal: Arq Bras Cir Dig Date: 2022-01-05